• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    2/7/24 2:18:56 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care
    Get the next $ALPA alert in real time by email
    SC 13G/A 1 d702651dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No. 3)*

     

     

    Carmell Corporation

    (Name of Issuer)

    Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    142922103

    (CUSIP Number)

    December 31, 2023

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

    (Continued on the Following Pages)

    (Page 1 of 7 Pages)

     

     

     


    CUSIP No. 142922103       Page 2 of 7

     

     1.   

     NAMES OF REPORTING PERSONS

     

     LINDEN CAPITAL L.P.

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     (a) ☒  (b) ☐

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Bermuda

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

     SOLE VOTING POWER

     

     0

       6.   

     SHARED VOTING POWER

     

     345,956

       7.   

     SOLE DISPOSITIVE POWER

     

     0

       8.   

     SHARED DISPOSITIVE POWER

     

     345,956

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     345,956

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.5%

    12.  

     TYPE OF REPORTING PERSON

     

     PN


    CUSIP No. 142922103       Page 3 of 7

     

     1.   

     NAMES OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

     LINDEN GP LLC

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     (a) ☒  (b) ☐

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

     SOLE VOTING POWER

     

     0

       6.   

     SHARED VOTING POWER

     

     345,956

       7.   

     SOLE DISPOSITIVE POWER

     

     0

       8.   

     SHARED DISPOSITIVE POWER

     

     345,956

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     345,956

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.5%

    12.  

     TYPE OF REPORTING PERSON

     

     HC


    CUSIP No. 142922103       Page 4 of 7

     

     1.   

     NAMES OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

     LINDEN ADVISORS LP

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     (a) ☒  (b) ☐

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Delaware

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

     SOLE VOTING POWER

     

     0

       6.   

     SHARED VOTING POWER

     

     371,248

       7.   

     SOLE DISPOSITIVE POWER

     

     0

       8.   

     SHARED DISPOSITIVE POWER

     

     371,248

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     371,248

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.6%

    12.  

     TYPE OF REPORTING PERSON

     

     IA, PN


    CUSIP No. 142922103       Page 5 of 7

     

     1.   

     NAMES OF REPORTING PERSONS

     I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

     

     SIU MIN WONG

     2.  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     

     (a) ☒  (b) ☐

     3.  

     SEC USE ONLY

     

     4.  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     China (Hong Kong) and USA

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5.    

     SOLE VOTING POWER

     

     0

       6.   

     SHARED VOTING POWER

     

     371,248

       7.   

     SOLE DISPOSITIVE POWER

     

     0

       8.   

     SHARED DISPOSITIVE POWER

     

     371,248

     9.   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     371,248

    10.  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11.  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.6%

    12.  

     TYPE OF REPORTING PERSON

     

     IN, HC


          Page 6 of 7

     

    This Amendment No. 3 (“Amendment No. 3”) is filed pursuant to Rule 13d-2(b) promulgated under the Securities Exchange Act of 1934, as amended, with respect to the Common Stock, par value $0.0001 per share (the “Shares”), of Carmell Corporation (formerly named “Alpha Healthcare Acquisition Corp. III”) (the “Issuer”) beneficially owned by the Reporting Persons specified herein as of December 31, 2023, and amends and supplements the Schedule 13G filed August 2, 2021, as amended by Amendment No. 1 thereto filed February 3, 2022 and Amendment No. 2 thereto filed February 3, 2023 (collectively, the “Schedule 13G”). Except as set forth herein, the Schedule 13G is unmodified.

    The names of the persons filing this statement on Amendment No. 3 are: Linden Capital L.P., a Bermuda limited partnership (“Linden Capital”), Linden Advisors LP, a Delaware limited partnership (“Linden Advisors”), Linden GP LLC, a Delaware limited liability company (“Linden GP”), and Mr. Siu Min (Joe) Wong (“Mr. Wong,” and collectively, the “Reporting Persons”).

     

    Item 4.

    Ownership:

    As of December 31, 2023, the Reporting Persons have ceased to be the beneficial owner of more than five percent of the outstanding Shares.

     

    Item 5.

    Ownership of Five Percent or Less of a Class:

    If this statement is being filed to report the fact that as of the date hereof the Reporting Persons have ceased to be the beneficial owner of more than five percent of the class of securities, check the following  ☒.

     

    Item 10.

    Certification:

    By signing below, the undersigned certifies that, to the best of its knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under Sec. 240.14a-11.


          Page 7 of 7

     

    SIGNATURES

    After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information with respect to it set forth in this statement is true, complete, and correct.

    Dated: February 6, 2024

     

    LINDEN CAPITAL L.P.
    By:   Linden GP LLC, its general partner
    By:   /S/ Saul Ahn
      Saul Ahn,
      Authorized Signatory

     

    LINDEN GP LLC
    By:   /S/ Saul Ahn
      Saul Ahn,
      Authorized Signatory
    LINDEN ADVISORS LP
    By:   /S/ Saul Ahn
      Saul Ahn,
      General Counsel
    SIU MIN WONG
    By:   /S/ Saul Ahn
      Saul Ahn, Attorney-in-Fact for Siu Min Wong**

     

    **

    Duly authorized under Siu Min Wong’s Power of Attorney, dated June 10, 2019, incorporated herein by reference to Exhibit B of the statement on Schedule 13G filed by Linden Capital L.P. on June 19, 2019 in respect of its holdings in Haymaker Acquisition Corp II.

    Get the next $ALPA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALPA

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $ALPA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Shukla Rajiv was granted 14,347 shares and acquired 0 shares, increasing direct ownership by 42% to 48,526 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    1/4/24 9:17:09 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the successful completion of its business combination (the "Business Combination") with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). The resulting combined company, Carmell Therapeutics Corporation, is expected to commence trading of its shares of common stock and warrants on the Nasdaq Capital Market® under the ticker symbols "CTCX" and "CTCXW," respectively, on July 17, 2023.

    7/14/23 3:12:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a non-binding letter of intent (the "LOI") to acquire a commercial stage regenerative medicine company (the "Target") conditioned upon the closing of ALPA's initial business combination with Carmell Therapeutics Corporation, a Phase 2 stage regenerative medicine platform company developing allogeneic plasma-based biomaterials for active soft tissue repair, aesthetics and orthopedic indications ("Carmell"). ALPA has set a Stockholders Meeting (the "Meeting") to consider the previously announced business combination with Carmell for J

    6/27/23 7:00:00 AM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications

    Alpha Healthcare Acquisition Corp. III (NASDAQ:ALPA) ("ALPA"), a special purpose acquisition company led by Mr. Rajiv Shukla, today announced the execution of a definitive business combination agreement with Carmell Therapeutics Corporation ("Carmell™"), a Phase 2-stage biotechnology platform company developing allogeneic plasma-based biomaterials for bone and soft tissue healing indications. Upon closing of the transaction, ALPA will be renamed Carmell Therapeutics Corporation (the "Combined Company"). Mr. Shukla will serve as Chairman and Mr. Randy Hubbell will serve as Chief Executive Officer of the Combined Company. The Combined Company's common stock is expected to be listed on the Na

    1/4/23 10:11:00 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    SEC Filings

    View All

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:27:40 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:14:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Alpha Healthcare Acquisition Corp. III filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Carmell Corp (0001842939) (Filer)

    1/16/24 7:07:47 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Cassaday Bryan J. bought $1,540 worth of shares (440 units at $3.50), increasing direct ownership by 29% to 1,940 units (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/19/23 5:00:05 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Spenlehauer Gilles bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:13:12 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    Frisch Scott M. bought $3,456 worth of shares (904 units at $3.82) (SEC Form 4)

    4 - Carmell Corp (0001842939) (Issuer)

    12/18/23 5:12:55 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    $ALPA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 4:13:13 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Alpha Healthcare Acquisition Corp. III (Amendment)

    SC 13G/A - Carmell Corp (0001842939) (Subject)

    2/14/24 3:42:33 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Alpha Healthcare Acquisition Corp. III

    SC 13G - Carmell Corp (0001842939) (Subject)

    2/14/24 12:54:27 PM ET
    $ALPA
    Medical/Dental Instruments
    Health Care